To our knowledge, this is the first study to evaluate dynamic changes in serum glucose, insulin, and glucagon levels along with incretin hormone secretion following different types of reconstruction after distal gastrectomy in patients with gastric cancer and T2D. The gene discussed is INS; the disease is gastric cancer.